JPS Oncology and Infusion Center ( Site 0083) — Fort Worth, Texas

JPS Oncology and Infusion Center ( Site 0083) is a clinical research site located in Fort Worth, Texas, United States 76104.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

JPS Oncology and Infusion Center ( Site 0083) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fort Worth

Browse all research sites in Texas · View every site in Fort Worth

• Texas Health Harris Methodist Hospital - Fort Worth - Neurology
• Harris Methodist Fort Worth Hospital
• University of North Texas Health Science Center
• Sensation-NOW: University of North Texas/John Peter Smith Hospital
• University of Texas Southwestern Medical Center
• RANGER: University of North Texas/John Peter Smith Hospital
• University of North Texas/Health Sciences Center-Fort Worth
• JP Smith Hospital
• Harris Methodist Southlake Hospital
• Cook's Children Hospital
• TBTC Site 20 UNTHSC (University of North Texas Health Science Center)
• John Peter Smith Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for JPS Oncology and Infusion Center ( Site 0083)?

JPS Oncology and Infusion Center ( Site 0083) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has JPS Oncology and Infusion Center ( Site 0083) conducted?

JPS Oncology and Infusion Center ( Site 0083) has 1 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms.

Is JPS Oncology and Infusion Center ( Site 0083) accredited by Crixeo Clinical Trials?

JPS Oncology and Infusion Center ( Site 0083) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about JPS Oncology and Infusion Center ( Site 0083)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.